{"cmr":"de-cm-kg/XETRA/B8FK","since":null,"total":10,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-11-07","event_type":"results","title":"Biofrontera Inc. to Report Third Quarter 2026 Financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/06/3397924/0/en/biofrontera-inc-to-report-third-quarter-2026-financial-results-on-november-13-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Lx2Yddzh9Y-saSP4KF3ENZju32UmxqfgyprtwVluq_G_LX5mtP4_UYA239GDkrrRhINY2nnJ92owEAywt7tFDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-02-17","event_type":"newswire_release","title":"Biofrontera Inc. Announces Database Lock of Phase 1","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/17/3239403/0/en/Biofrontera-Inc-Announces-Database-Lock-of-Phase-1-Pharmacokinetics-Study-of-Ameluz-for-Actinic-Keratoses-on-Trunk-and-Extremities.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ntChTZZ75lDmtvefuSy9f5IwgUaRYjI-hRFERIIQRPaLmONKOXm1K-MJx2HKODQUaIn9F9CoiX8Idv_GnZgwBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-02-11","event_type":"newswire_release","title":"Biofrontera Announces FDA Filing Acceptance of Supplemental","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/11/3236372/0/en/biofrontera-announces-fda-filing-acceptance-of-supplemental-new-drug-application-for-ameluz-pdt-in-superficial-basal-cell-carcinoma.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"--6qR09hbqBY_90vlYZhpCEtxNPUgFpAP3bvmkCmUIImadAStxD9wdcV6Oc8EIodM61zn5Dx4s03oAqvBYWqBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-02-11","event_type":"newswire_release","title":"Biofrontera Announces FDA Filing Acceptance of Supplemental","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2026/02/11/3236372/0/en/Biofrontera-Announces-FDA-Filing-Acceptance-of-Supplemental-New-Drug-Application-for-Ameluz-PDT-in-Superficial-Basal-Cell-Carcinoma.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RuNOW687KFuBAFaArHYm_3MTbtk9ppwhXoiS-iA9et79p2zPOHVVX6NAnzIPE8r-_9kTA2XAd3B5H3MaDYfuBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-02-09","event_type":"newswire_release","title":"Biofrontera Announces Positive Results in Phase 3 Study of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/02/09/3234622/0/en/Biofrontera-Announces-Positive-Results-in-Phase-3-Study-of-Ameluz-PDT-for-Actinic-Keratoses-on-the-Extremities-Neck-and-Trunk-Meeting-Primary-Endpoint.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3RSL2OtrMiyDBIIg3Hz-wozX3djNL7KH1HrmtxzH8peJjzEJREFBrXk0KfRwy9APYA26Sj29UBeOP3kA7pf_Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2026-01-13","event_type":"newswire_release","title":"Biofrontera Inc. Announces Record Preliminary Fourth","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/01/13/3217820/0/en/biofrontera-inc-announces-record-preliminary-fourth-quarter-2025-revenues-between-17-0-million-and-17-5-million-representing-approximately-35-year-over-year-growth.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jGA-nujdzvWhj5BlFXjroJ1brT-0iCJ61yLzGz_VfVj7JamGIbaDqpu0-S4rkahMSeUVmZM1omrliNaNuJvGBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2025-12-02","event_type":"newswire_release","title":"Biofrontera Inc. Announces Filing of Supplemental New Drug","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/12/02/3197970/0/en/Biofrontera-Inc-Announces-Filing-of-Supplemental-New-Drug-Application-sNDA-for-the-Treatment-of-Superficial-Basal-Cell-Carcinoma-sBCC-with-Ameluz-PDT.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CBtn0wT_E9i2jcIirEBPb9zlNJNTs9gqm98Qln5uN84JduywrhD5JArJwxQYW5sBFHtmJq3QBv2TXt_MKuRrAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2025-11-06","event_type":"results","title":"Biofrontera Inc. to Report Third Quarter 2025 Financial","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/06/3183042/0/en/Biofrontera-Inc-to-Report-Third-Quarter-2025-Financial-Results-on-November-12-2025-and-Host-a-Conference-Call-on-November-13-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ocSvy5c6kEpdb5MIrzCJbr1huVSKq8dft-HNFYFSf6HunyMDZpo-S7qNFmbkfiDKYwc-0zG9fOYDkaRNeiwbAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2025-09-26","event_type":"newswire_release","title":"Biofrontera Inc. to Participate in the Lytham Partners Fall","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/26/3157049/0/en/Biofrontera-Inc-to-Participate-in-the-Lytham-Partners-Fall-2025-Investor-Conference-on-September-30-2025.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ULdhIkAmCF3fzh4icK-TB2wojqNuSqAeNbepiU9jFZQakYSmeNYIDfxxJHKms7JTpvEX9IkrHcYGwTE1HzlRBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"de-cm-kg/XETRA/B8FK","date":"2025-09-16","event_type":"newswire_release","title":"Biofrontera Inc. Announces Last Patient Out in Phase 3","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/16/3150998/0/en/Biofrontera-Inc-Announces-Last-Patient-Out-in-Phase-3-Study-of-Ameluz-aminolevulinic-acid-HCI-Topical-Gel-10-Photodynamic-Therapy-PDT-for-the-Treatment-of-Actinic-Keratoses-AK-on-t.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"cGGkovQPmvQ7xTzNr5-MIo_EQkuLbVmFJNYviedPOes1UMuHleUneHZBmVh4D_98XaCSBjrVGb8EheIj9-URCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}